Your browser doesn't support javascript.
loading
Impact of depatuxizumab mafodotin on health-related quality of life and neurological functioning in the phase II EORTC 1410/INTELLANCE 2 trial for EGFR-amplified recurrent glioblastoma.
Clement, Paul M J; Dirven, Linda; Eoli, Marica; Sepulveda-Sanchez, Juan M; Walenkamp, Annemiek M E; Frenel, Jean S; Franceschi, Enrico; Weller, Michael; Chinot, Olivier; De Vos, Filip Y F L; Whenham, Nicolas; Sanghera, Paul; Looman, Jim; Kundu, Madan G; Peter de Geus, Jan; Nuyens, Sarah; Spruyt, Maarten; Gorlia, Thierry; Coens, Corneel; Golfinopoulos, Vassilis; Reijneveld, Jaap C; van den Bent, Martin J.
Afiliação
  • Clement PMJ; Department of Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Electronic address: paul.clement@uzleuven.be.
  • Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands. Electronic address: l.dirven@lumc.nl.
  • Eoli M; Unit of Molecular Neuro-Oncology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. Electronic address: marica.eoli@istituto-besta.it.
  • Sepulveda-Sanchez JM; Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: jmsepulveda76@gmail.com.
  • Walenkamp AME; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands. Electronic address: a.walenkamp@umcg.nl.
  • Frenel JS; Medical Oncology, Institut de Cancerologie de L'Ouest, Saint-Herblain, France. Electronic address: Jean-Sebastien.Frenel@ico.unicancer.fr.
  • Franceschi E; Medical Oncology Department, AUSL / IRCCS Institute of Neurological Sciences, Bologna, Italy. Electronic address: enricofra@yahoo.it.
  • Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: michael.weller@usz.ch.
  • Chinot O; Aix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service de Neuro-Oncologie, Marseille, France. Electronic address: olivier.chinot@ap-hm.fr.
  • De Vos FYFL; Department of Medical Oncology, University Medical Center Utrecht, University Utrecht, Utrecht, the Netherlands. Electronic address: f.devos@umcutrecht.nl.
  • Whenham N; Cliniques Universitaires Saint-Luc, Brussels, Belgium. Electronic address: nicolas.whenham@uclouvain.be.
  • Sanghera P; University Hospitals Birmingham, Edgbaston, Birmingham, United Kingdom. Electronic address: paul.sanghera@uhb.nhs.uk.
  • Looman J; Pharmaceutical Development, AbbVie, Hoofddorp, the Netherlands. Electronic address: jim.looman@abbvie.com.
  • Kundu MG; Statistics, AbbVie Inc, North Chicago, IL, USA. Electronic address: madan_g.kundu@yahoo.com.
  • Peter de Geus J; Clinical Program Development, AbbVie, Hoofddorp, the Netherlands. Electronic address: jan.peter.de.geus@abbvie.com.
  • Nuyens S; EORTC, Brussels, Belgium. Electronic address: sarah.nuyens@eortc.org.
  • Spruyt M; EORTC, Brussels, Belgium. Electronic address: maarten.spruyt@eortc.org.
  • Gorlia T; EORTC Headquarters, Brussels, Belgium. Electronic address: thierry.gorlia@eortc.org.
  • Coens C; EORTC Headquarters, Brussels, Belgium. Electronic address: corneel.coens@eortc.org.
  • Golfinopoulos V; EORTC Headquarters, Brussels, Belgium. Electronic address: Vassilis.golfinopoulos@eortc.org.
  • Reijneveld JC; Brain Tumor Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands. Electronic address: jc.reijneveld@amsterdamumc.nl.
  • van den Bent MJ; Department of Neurology, Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.
Eur J Cancer ; 147: 1-12, 2021 04.
Article em En | MEDLINE | ID: mdl-33601293
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Amplificação de Genes / Glioblastoma / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Neoplasias Encefálicas / Protocolos de Quimioterapia Combinada Antineoplásica / Amplificação de Genes / Glioblastoma / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos / Recidiva Local de Neoplasia Tipo de estudo: Clinical_trials / Diagnostic_studies Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Eur J Cancer Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido